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Sodium  satiety  is  disrupted  by  gabaergic  activation  in  the  LPBN.
Central  cholinergic  mechanisms  facilitate  sodium  intake  to  muscimol  into  the  LPBN.
Inhibition  of  central  cholinergic  mechanisms  by  LPBN  is  essential  for sodium  satiety.
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a  b  s  t  r  a  c  t
Bilateral  injections  of  the  GABAA agonist  muscimol  into  the  lateral  parabrachial  nucleus  (LPBN)  dis-
rupt  satiety  and  induce  strong  ingestion  of  water  and  0.3  M NaCl  in ﬂuid-replete  rats  by  mechanisms
not  completely  clear.  In  the  present  study,  we  investigated  the  effects  of  the  blockade  of  central
muscarinic  cholinergic  receptors  with  atropine  injected  intracerebroventricularly  (i.c.v.)  on  0.3 M NaCl
and water  intake  induced  by  muscimol  injections  into  the  LPBN  in ﬂuid-replete  rats.  Male  Holtz-
man  rats  with  stainless  steel  cannulas  implanted  bilaterally  into  the  LPBN  and  unilaterally  into  the
lateral  ventricle  (LV) were  used.  Bilateral  injections  of  muscimol  (0.5  nmol/0.2  L) into  the LPBN
induced  0.3 M NaCl  (32.2  ± 9.9  mL/4  h,  vs.  saline:  0.4  ±  0.2  mL/4  h)  and  water  intake  (11.4 ±  4.4  mL/4  h,
vs.  saline:  0.8  ±  0.4  mL/4  h)  in  ﬂuid-replete  rats  previously  treated  with  i.c.v.  injection  of  saline.  The  pre-
vious  i.c.v.  injection  of  atropine  (20  nmol/1  L) reduced  the  effects  of  LPBN-muscimol  on  0.3 M  NaCl
(13.5  ±  5.0  mL/4  h)  and  water  intake  (2.9  ±  1.6 mL/4  h).  The  i.c.v. injection  of  atropine  did  not  affect  0.3  M
NaCl  (26.8  ± 6.2  mL/2  h,  vs.  saline  i.c.v.:  36.5  ±  9.8 mL/2  h)  or  water  intake  (14.4  ±  2.5  mL/2  h, vs.  saline
i.c.v.:  15.6  ± 4.8  mL/2  h)  in  rats  treated  with  furosemide  + captopril  subcutaneously  combined  with  bilat-
eral injections  of  moxonidine  (2-adrenoceptor/imidazoline  agonist,  0.5  nmol/0.2  L) into  the  LPBN,
suggesting  that  the  effect  of  atropine  was  not  due  to  non-speciﬁc  inhibition  of  ingestive  behaviors.  The
results  show  that  active  central  cholinergic  mechanisms  are  necessary  for the hypertonic  NaCl  and  water
intake  induced  by  the blockade  of  the  inhibitory  mechanisms  with  injections  of  muscimol  into  the  LPBN
in ﬂuid-replete  rats. The  suggestion  is  that  in  ﬂuid-replete  rats  the  action  of  LPBN  mechanisms  inhibits
ced  bfacilitatory  signals  produ
. IntroductionWater and mainly sodium intake is under strong control
f inhibitory mechanisms from the lateral parabrachial nucleus
LPBN), a pontine structure located dorsolaterally to the superior
Abbreviations: ANG II, angiotensin II; CAP, captopril; CCK, cholecystokinin;
RF,  corticotrophin release factor; DOCA, deoxycorticosterone acetate; FURO,
urosemide; i.c.v., intracerebroventricular; LPBN, lateral parabrachial nucleus; LV,
ateral ventricle; NTS, nucleus of the solitary tract; OVLT, organum vasculosum of
he lamina terminalis; s.c., subcutaneous; SFO, subfornical organ.
∗ Corresponding author. Tel.: +55 16 3301 6486; fax: +55 16 3301 6488.
E-mail address: menani@foar.unesp.br (J.V. Menani).
304-3940     © 2012 Elsevier Ireland Ltd. 
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Open access under the Elsevier OA license.y the  activity  of  central  cholinergic  mechanisms  to  maintain  satiety.
© 2012 Elsevier Ireland Ltd.
cerebellar peduncle [6,7,10,14,26,28,29]. Electrolytic or neurotoxic
lesions of the LPBN increase water intake induced by angiotensin
II (ANG II) [15,27,28].  Bilateral injections of the serotonergic recep-
tor antagonist methysergide into the LPBN increase water and/or
0.3 M NaCl intake induced by ANG II injected intracerebroventric-
ularly (i.c.v.) or into the subfornical organ (SFO), i.c.v. injection of
the cholinergic agonist carbachol, subcutaneous (s.c.) injection of
deoxycorticosterone (DOCA), 24 h of sodium depletion or by the
treatment with the diuretic furosemide (FURO) combined with a
low dose of the angiotensin converting enzyme inhibitor capto-
Open access under the Elsevier OA license.pril (CAP) [7,8,12,22,23,25,26]. The activation of 2-adrenoceptors
or the blockade of cholecystokinin (CCK), corticotrophin release
factor (CRF) or glutamate receptors in the LPBN also increases
0.3 M NaCl intake induced by FURO + CAP, suggesting that
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ifferent neurotransmitters in the LPBN modulate important
nhibitory mechanisms for the control of sodium and water intake
hat acts by reducing or limiting the ingestion induced by dif-
erent facilitatory stimuli and, therefore, contributing to satiety
3,9–11,18,24].
The importance of the LPBN inhibitory mechanisms for sodium
atiety is also suggested by studies that have tested the effects
f GABAergic activation in the LPBN in ﬂuid-replete rats [6,30].
n this condition, bilateral injections of the GABAA receptor ago-
ist muscimol into the LPBN induce a robust and rapid (within
–4 h) ingestion of 0.3 M NaCl and water in a two-bottle test, with-
ut increasing renal sodium excretion [6,30].  Therefore, it seems
hat only the deactivation of the inhibitory mechanisms with the
njections of muscimol into the LPBN, without the additional acti-
ation of facilitatory mechanisms is enough to disrupt satiety and
rive ﬂuid-replete rats to ingest hypertonic NaCl [6].  However, to
onﬁrm or to refute this hypothesis it is important to investigate
he involvement of facilitatory mechanisms on LPBN muscimol-
nduced sodium and water intake. In part, this was  already tested
n a previous study that showed that the ingestion of 0.3 M NaCl
nd water induced by muscimol injected into the LPBN was  par-
ially reduced by the i.c.v. injections of the AT1 receptor antagonist
osartan, suggesting that in this case sodium appetite depends on
he blockade of the LPBN inhibitory mechanisms together with
imultaneous activation of facilitatory mechanisms [30].
Even a high dose of losartan injected i.c.v. only partially reduced
PBN muscimol induced hypertonic NaCl and water intake, sug-
esting that ANG II is not the only facilitatory mechanism involved
n LPBN muscimol-induced sodium and water intake in ﬂuid-
eplete rats. Therefore, with the purpose to ﬁnd another possible
acilitatory mechanism involved on LPBN muscimol-induced water
nd sodium intake, in the present study, we investigated the
ffects of the blockade of central muscarinic cholinergic receptors
ith i.c.v. injection of atropine on 0.3 M NaCl and water intake
nduced by the injections of muscimol into the LPBN in ﬂuid-replete
ats. Although central cholinergic stimulation produces no sodium
ntake in ﬂuid-replete rats, the combination of central cholinergic
ctivation with the blockade of LPBN serotonergic inhibitory mech-
nisms induces hypertonic NaCl intake in ﬂuid-replete rats [22]. To
how that the effects of i.c.v. atropine on water and 0.3 M NaCl
ntake were not due to non speciﬁc inhibition of ingestive behav-
ors, we tested also the effects of i.c.v. atropine on water and 0.3 M
aCl intake produced by moxonidine injected into the LPBN in rats
reated with FURO + CAP s.c.
. Experimental procedures
.1. Animals
Male Holtzman rats weighing 280–320 g were used. Animals
ere housed in individual stainless steel cages with free access to
ormal sodium diet (Guabi Rat Chow, Paulínia, SP, Brazil), water
nd 0.3 M NaCl solution. Rats were maintained in a room with
emperature at 23 ± 2 ◦C, humidity 55 ± 10% and a 12:12 light-dark
ycle with light onset at 7:00 AM.  All the experimental procedures
ere approved by Ethical Committee for Animal Experimentation
CEEA) from School of Dentistry of Araraquara – UNESP (CEEA
7/2008 and CEEA 31/2010). The experimental protocols followed
he U.S. National Institutes of Health Guide for the Care and Use of
aboratory Animals (NIH publication no. 80-23, 1996)..2. Brain surgery
Rats were anesthetized with ketamine (80 mg/kg of body
eight, Cristália, Itapira, Brazil) combined with xylazine (7 mg/kgtters 534 (2013) 188– 192 189
of body weight, Agener União, Embu-Guac¸ u, Brazil) intraperi-
toneally, placed in a stereotaxic instrument (Kopf 900, Tujunga,
CA, USA) and had the skull leveled between bregma and lambda.
Stainless steel 23-gauge guide cannulas were implanted bilaterally
into the LPBN (coordinates: 9.4 mm caudal to bregma, 2.1 mm lat-
eral to midline and 4.0 mm  below dura mater) and a third cannula
was  implanted in direction to the left lateral ventricle (LV; coor-
dinates: 0.3 mm caudal to bregma, 1.6 mm  lateral to midline and
3.6 mm below the skull). The tips of the guide cannulas were pos-
itioned at a point 2 mm above the LPBN and 1 mm  above the LV.
The guide cannulas were ﬁxed to the cranium using dental acrylic
resin and jeweler screws. A 30-gauge metal obturator ﬁlled the
guide cannulas between tests. At the end of the surgery, the animals
received an intramuscular injection of antibiotic (benzylpenicillin
– 80,000 IUs plus streptomycin – 33 mg;  Pentabiótico Veterinário
– Pequeno Porte, Fort Dodge Saude Animal, Campinas, Brazil) and
a s.c. injection of the analgesic/anti-inﬂammatory 1% ketoprofen
(0.03 mL/rat; Ketoﬂex, Mundo Animal, São Paulo, Brazil).
After the surgery, rats were allowed to recover for 5 days before
starting water and 0.3 M NaCl intake tests.
2.3. Drugs
Muscimol HBr (GABAA receptor agonist, 0.5 nmol/0.2 L) from
Research Biochemicals Internationals, Natick, MA,  USA and
moxonidine hydrochloride (2-adrenoceptor/imidazoline agonist,
0.5 nmol/0.2 L) a donation from Solvay Pharma, Hannover,
Germany, were administered into the LPBN. Atropine methyl bro-
mide (muscarinic receptor antagonist, 20 nmol/1 L) from Sigma
Chemical Co., Saint Louis, MO,  USA was administered into the LV.
Atropine and muscimol were dissolved in saline (0.9% NaCl) and
moxonidine was dissolved in a mix  of propylene glycol and water
2:1 (vehicle).
Furosemide (natriuretic/diuretic, 10 mg/kg of body weight s.c.)
from Sigma Chem., St Louis, MO,  USA was dissolved in alkaline
saline (pH adjusted to 9.0 with NaOH). Captopril (angiotensin con-
verting enzyme inhibitor, 5 mg/kg of body weight s.c.) from Sigma
Chem., St. Louis, MO,  USA was dissolved in saline.
2.4. Central injections
Injections into the LPBN and LV were made using 5 L Hamil-
ton syringes (Hamilton, Reno, NV, USA) connected by polyethylene
tubing (PE-10) to 30-gauge injection cannula (2 mm longer than the
guide cannula). The injection volumes into the LPBN and LV were
0.2 L and 1.0 L, respectively.
2.5. Water and 0.3 M NaCl intake tests
2.5.1. Tests in ﬂuid-replete rats
Rats were tested in their home cages with no access to food
during the test. Water and 0.3 M NaCl were provided from burettes
with 0.1 mL  divisions that were ﬁtted with metal drinking spouts.
Cumulative water and 0.3 M NaCl intake was recorded at every
30 min  for 4 h starting immediately after bilateral injections of mus-
cimol (0.5 nmol/0.2 L) or saline into the LPBN. Immediately before
the LPBN injections, the rats also received injections of atropine
(20 nmol/1 L) or saline into the LV. The rats were submitted to
3 tests and received the following combinations of treatments:
(1) saline into the LV + saline into the LPBN; (2) saline into the
LV + muscimol into the LPBN; (3) atropine into the LV + muscimol
into the LPBN. In each test, the group of rats was divided in two  and
half of the group received one of the combination of treatments
cited above and the remaining animals received another combina-
tion of treatments. The sequence of the treatments in each rat in
1 nce Letters 534 (2013) 188– 192
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Fig. 1. Cumulative (A) 0.3 M NaCl and (B) water intake by satiated rats that received
bilateral injections of muscimol (0.5 nmol/0.2 L) or saline into LPBN combined
with i.c.v. injection of atropine (20 nmol/1 L) or saline. Values are reported as90 D.S. Asnar et al. / Neuroscie
he different tests was randomized and at the end of 3 tests each
at received all the 3 treatments.
A recovery period of at least 2 days was allowed between the
ests.
.5.2. Tests in FURO + CAP-treated rats
Water and 0.3 M NaCl intake was induced by s.c. injections of
URO (10 mg/kg of body weight) + CAP (5 mg/kg of body weight).
mmediately after the treatment with FURO + CAP, the rats were
aintained without water or 0.3 M NaCl for 1 h. After this period,
ater and 0.3 M NaCl were offered to the animals and the cumula-
ive intake was recorded at every 30 min  for 2 h.
Vehicle or moxonidine (0.5 nmol/0.2 L) was injected into the
PBN 15 min  before the access to water and 0.3 M NaCl. Atropine
20 nmol/1 L) or saline was injected into the LV 15 min  before the
njections into the LPBN.
A recovery period of at least 2 days was allowed between the
ests. During the tests rats had no access to food.
.6. Histology
At the end of the last test, the rats received injections of 2%
vans Blue solution (0.2 L). They were then deeply anesthetized
ith sodium thiopental (Cristália, Brazil, 80 mg/kg of body weight)
nd perfused transcardially with saline followed by 10% forma-
in. Brains were removed, ﬁxed in 10% formalin, frozen, cut in
0 m sections, stained with Giemsa stain, and analyzed by light
icroscopy to conﬁrm the injection sites into the LPBN and LV.
.7. Statistical analysis
Results are reported as means ± SEM. Two way analysis of vari-
nce (ANOVA) using treatments and times as factors followed by
ewman–Keuls tests were used for comparisons. Differences were
onsidered signiﬁcant at p < 0.05.
. Results
.1. Water and 0.3 M NaCl intake induced by gabaergic activation
n the LPBN in rats pre-treated with i.c.v. injection of atropine
Bilateral injections of muscimol (0.5 nmol/0.2 L) into the
PBN in ﬂuid-replete rats pre-treated with i.c.v. injections
f saline induced 0.3 M NaCl (32.2 ± 9.9 mL/4 h, vs. saline
nto LPBN: 0.4 ± 0.2 mL/4 h) [F(2,14) = 8.40; p < 0.05] and water
ntake (11.4 ± 4.4 mL/4 h, vs. saline into LPBN: 0.8 ± 0.4 mL/4 h)
F(2,14) = 6.85; p < 0.05] (Fig. 1). The injections of atropine
20 nmol/1 L) i.c.v. reduced the effects of LPBN muscimol
njections on 0.3 M NaCl (13.5 ± 5.0 mL/4 h) and water intake
2.9 ± 1.6 mL/4 h) (Fig. 1).
.2. Water and 0.3 M NaCl intake induced by FURO + CAP in rats
reated with moxonidine into the LPBN combined with i.c.v.
njection of atropine
In rats pre-treated with saline i.c.v., bilateral injections of
oxonidine (0.5 nmol/0.2 L) into the LPBN increased FURO + CAP-
nduced 0.3 M NaCl intake (36.5 ± 9.8 mL/2 h, vs. vehicle into LPBN:
.6 ± 2.0 mL/2 h) [F(2,12) = 5.97; p < 0.05] (Fig. 2). The pre-treatment
ith atropine (20 nmol/1 L) injected i.c.v. did not change 0.3 M
aCl intake produced by combining FURO + CAP s.c. with mox-
nidine injected into the LPBN (26.8 ± 6.2 mL/2 h) (Fig. 2). Water
ntake induced by FURO + CAP s.c. was not modiﬁed by the injec-
ions of moxonidine into the LPBN in rats pre-treated with saline
.c.v. (15.6 ± 4.8 mL/2 h, vs. vehicle into LPBN: 9.1 ± 2.6 mL/2 h)means ± SEM; n = number of animals.
or pre-treated with i.c.v. injection of atropine (14.4 ± 2.5 mL/2 h)
[F(2,12) = 0.48; p > 0.05] (Fig. 2).
4. Discussion
The present results show that water and 0.3 M NaCl intake
induced by bilateral injections of muscimol into the LPBN in
ﬂuid-replete rats was reduced by i.c.v. injection of the muscarinic
cholinergic antagonist atropine, suggesting that central cholinergic
mechanisms probably from the forebrain facilitate 0.3 M NaCl and
water intake when the inhibitory mechanisms are deactivated with
bilateral injections of muscimol into the LPBN. The i.c.v. injection of
atropine did not affect water and 0.3 M NaCl intake in rats treated
with FURO + CAP combined with injections of moxonidine into the
LPBN, conﬁrming that the reduction of LPBN muscimol-induced
water and sodium intake is not due to non speciﬁc inhibition
of ingestive behaviors by the i.c.v. injection of atropine. At the
dose tested (20 nmol/1 L), atropine injected into the LV almost
abolished water intake induced by the cholinergic agonist car-
bachol (4 nmol/1 L) also injected into the LV (1.9 ± 1.0 mL/2 h,
D.S. Asnar et al. / Neuroscience Le
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an  rats treated with bilateral injections of moxonidine (0.5 nmol/0.2 L) or vehicle
nto LPBN combined with i.c.v. injection of atropine (20 nmol/1 L) or saline. Values
re  reported as means ± SEM; n = number of animals.
s. saline + carbachol into the LV: 8.6 ± 1.5 mL/2 h; n = 5), demon-
trating that this dose of atropine is effective in blocking central
uscarinic receptors.
Muscimol injected into the LPBN in ﬂuid-replete rats induces
nly a small ingestion of water when only water is available [6],
uggesting that the strong ingestion of water by ﬂuid-replete rats
reated with muscimol into the LPBN when both water and 0.3 M
aCl are simultaneously available is likely a consequence of the
ncreased osmolarity of body ﬂuids due to the excessive ingestion
f hypertonic NaCl. Therefore, the main reason for the reduced
ngestion of water caused by the i.c.v. injection of atropine in
ats treated with muscimol into the LPBN is probably the reduced
ngestion of hypertonic NaCl. However, considering the importance
f the central cholinergic mechanisms for water deprivation- or
yperosmolarity-induced water intake [5,21],  it is not possible to
ompletely exclude a direct effect of central muscarinic blockade
educing water intake.
Similar to the increase in plasma osmolarity, central choliner-
ic activation induces water intake and was suggested to inhibit
odium intake [16,17]. In spite of this classical concept, the i.c.v.
njection of the cholinergic agonist carbachol stimulates hypertonic
aCl intake in ﬂuid-replete rats treated with bilateral injections
f the serotonergic antagonist methysergide into the LPBN, sug-
esting that, besides water intake, central cholinergic mechanisms
lso facilitate sodium intake when LPBN inhibitory mechanisms aretters 534 (2013) 188– 192 191
deactivated [22]. To explain the paradoxical facilitation of hyper-
tonic NaCl intake by a mechanism recognized as inhibitory for
sodium intake like increased plasma osmolarity, De Luca Jr et al.
[13] proposed that plasma hyperosmolarity simultaneously acti-
vates two parallel central circuitries: one that facilitates thirst and
sodium appetite and another dependent on the LPBN that inhibits
sodium intake. The activity of the inhibitory mechanism completely
opposes to the action of the facilitatory mechanism and the result
is no sodium intake by hyperosmotic rats. However, the activa-
tion of facilitatory mechanisms by the hyperosmolarity drives rats
to ingest hypertonic NaCl besides water if the LPBN inhibitory
mechanisms were deactivated [4,13].  Mechanisms similar to those
proposed to explain the effects of increased osmolarity on sodium
intake might also explain the suggested opposite effects of the cen-
tral cholinergic mechanisms on sodium intake.
In the present study, rats were ﬂuid-replete and, therefore, prob-
ably satiated. In this condition it was expected that the facilitatory
mechanisms were deactivated and the action of the inhibitory
mechanisms, if they were activated, not so important to maintain
satiety in the absence of the activity of facilitatory mechanisms.
However, the strong ingestion of 0.3 M NaCl by rats treated with
muscimol injected into the LPBN suggests exactly the opposite, i.e.
that sodium appetite in a condition of satiety is under strong con-
trol of the inhibitory mechanisms. The present and the previous
studies [30] suggest that LPBN inhibitory mechanisms are essen-
tial to maintain sodium satiety and that central angiotensinergic
and cholinergic mechanisms may  stimulate sodium intake if the
LPBN inhibitory mechanisms were deactivated in ﬂuid-replete rats.
Even considering that the cholinergic mechanisms may  also inhibit
sodium intake, as commented above, the blockade of LPBN mech-
anisms might abolish the inhibitory effect and, then, the result of
the central cholinergic activation in rats treated with muscimol into
the LPBN is also the facilitation of hypertonic NaCl ingestion.
Although i.c.v. atropine reduced LPBN muscimol-induced water
and sodium intake, the same i.c.v. treatment produced no change of
water and 0.3 M NaCl intake induced by FURO + CAP in rats treated
with moxonidine into the LPBN, suggesting that central cholin-
ergic mechanisms are not involved in the ingestion of sodium
or water in this condition and, therefore, that the effects of i.c.v.
atropine are not due to non-speciﬁc inhibition of ingestive behav-
iors. Moxonidine acting on 2 adrenoceptors in the LPBN increases
water and sodium intake induced by FURO + CAP, i.e. increases
an ingestion caused by ANG II acting on central AT1 receptors in
ﬂuid depleted rats, however, moxonidine injected into the LPBN
produces no change of water or sodium intake in ﬂuid-replete
rats [3].  Therefore, moxonidine injected into the LPBN only affects
NaCl and water intake if a facilitatory mechanism like ANG II is
simultaneously activated [3].  The difference in the condition for
muscimol and moxonidine injected into the LPBN to produce effects
on sodium and water intake is likely related to which inhibitory
signals are affected by each treatment. Moxonidine injected into
the LPBN increases hedonic and reduces aversive responses to
an intra-oral infusion of 0.3 M NaCl, suggesting that moxonidine
acting in the LPBN reduces the inﬂuence of inhibitory taste sig-
nals activated by the ingestion of hypertonic NaCl, increasing the
palatability of NaCl and consequently the ingestion of hypertonic
NaCl [2].  Besides taste signals, other inhibitory signals like those
from peripheral baroreceptors and cardiopulmonary receptors also
reach the LPBN. It seems that, muscimol acting in the LPBN removes
all the inhibitory signals involved in the control of sodium intake
and, therefore, in this condition any baseline angiotensinergic or
cholinergic facilitatory signal still present in ﬂuid-replete rats is
enough to disrupt satiety and to drive satiated rats to ingest NaCl
[6,30] the present results]. Probably baseline levels of ANG II and
acetylcholine activate the respective receptors in the SFO and the
organum vasculosum of the lamina terminalis (OVLT). The SFO
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ends projections to the central nucleus of the amygdala (CeA),
hich also receives projections from the LPBN [19,20].  Sodium
ntake produced by blockade of LPBN neurons with muscimol
epends on the integrity of the CeA [1].  Therefore, it seems that
ignals from the SFO and OVLT reach CeA and in this area they are
odulated by the inhibitory signals from the LPBN. However, with
he information available it is not possible to exclude that a differ-
nt area, still unknown, integrates the facilitatory signals from the
eA and the inhibitory signals from the LPBN.
In conclusion, the present results show that central cholinergic
echanisms stimulate 0.3 M NaCl and water intake if the inhibitory
echanisms were deactivated by muscimol injected into the LPBN
n ﬂuid-replete rats. This suggests that the action of LPBN mecha-
isms inhibits facilitatory signals produced by the activity of central
holinergic mechanisms to maintain satiety in ﬂuid-replete rats.
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